Figure 1.

Trajanoski and colleagues [ 3 ] use high-resolution genomic analysis to identify tumor immunophenotypes and predict tumor antigens. Associations between these parameters and various molecular and clinical tumor phenotypes were determined, and are shown above as connecting lines. The findings corroborate previous work, generate new hypotheses regarding tumor-immune interactions, and identify putative novel targets for immunotherapy. GSEA, gene set enrichment analysis; MHC, major histocompatibility complex.